News ArticleMore News »
Novum’s Pina D’Angelo Presented at ICSA Symposium
Jun 12, 2017
Pittsburgh, PA: Pina D’Angelo, MSc, Novum’s Executive Director, Scientific Affairs (Biostatistics), was a Presenter at the 2017 ICSA Applied Statistics Symposium, on June 25th – 28thin Chicago, Illinois.
On June 28th at 9:45AM, Ms. D’Angelo discussed the topic of “Statistical Analysis and Issues in Skin Adhesion Studies”. This session provided an overview of the regulatory requirements for generic submissions of transdermal/topical patch systems with a focus on the design of and statistical analyses for adhesion studies.
For over 40 years, Novum has been considered one of the world’s leaders in the conduct of clinical trials; Early Phase Research from First in Human studies to large bioequivalence studies are conducted at Clinical Pharmacology units in Houston, Texas; Las Vegas, Nevada; and Fargo, North Dakota. A separate division, managing Late Phase Research requiring patient populations across multiple therapeutic areas, is lead by the Clinical Trials Division headquartered in Pittsburgh, Pennsylvania.